Cellebrain
Developer of a stem cell-based gene therapy platform designed to treat neurological disorders. The company's platform develops drugs based on a pipeline of stem cell-based gene therapy candidates that...
Valuation
$21.8M
Latest known
Share Price
N/A
Total Raised
$3.6M
Last Round
N/A